NEOPHARM, Inc. (NEOL) Tops Q2 EPS by 6c
NEOPHARM, Inc. (NASDAQ: NEOL) reports a Q2 loss of $0.13, 6 cents better than estimates.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
